- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01255748
Registry Study for Radiation Therapy Outcomes
February 26, 2024 updated by: Proton Collaborative Group
Evaluation Tracking Project: A Prospective Chart Review of Patients Treated With Radiation Therapy
The purpose of this research study is to collect and analyze information from patients being treated with various forms of radiation therapy.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
40000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Matthew Morocco
- Phone Number: 630-836-8670
- Email: mmorocco@pcgresearch.org
Study Contact Backup
- Name: Karen Brown
- Phone Number: 630-836-8668
- Email: kbrown@pcgresearch.org
Study Locations
-
-
Arizona
-
Scottsdale, Arizona, United States, 85259-5499
- Recruiting
- Mayo Clinic
-
Contact:
- Clinical Trials Office - All Mayo Clinic Locations
- Phone Number: 855-776-0015 (toll free)
-
-
California
-
San Diego, California, United States, 92121
- Recruiting
- California Protons Cancer Therapy Center
-
Contact:
- Alexandra Crawford, MPH
- Phone Number: 858-549-7431
- Email: alexandra.crawford@californiaprotons.com
-
Principal Investigator:
- James Urbanic, MD
-
-
Florida
-
Delray Beach, Florida, United States, 33484
- Recruiting
- South Florida Proton Therapy Institute
-
Principal Investigator:
- James Snider, MD
-
Contact:
- Salina Ramirez
- Phone Number: 561-323-6360
- Email: sramirez@sfpti.com
-
Jacksonville, Florida, United States, 32223
- Recruiting
- Ackerman Cancer Center
-
Principal Investigator:
- Ryan Perkins, MD
-
Contact:
- Mitchell Urmann
- Phone Number: 904-880-5522
- Email: mitchellu@ackermancancer.com
-
Miami, Florida, United States, 33176
- Recruiting
- Miami Cancer Institute
-
Contact:
- Alex Kudryashev
- Phone Number: 786-596-2000
- Email: alexku@baptisthealth.net
-
Principal Investigator:
- Michael Chuong, MD
-
Orlando, Florida, United States, 32806
- Recruiting
- Orlando Health Cancer Institute
-
Contact:
- Leila IP, BSN, RN
- Phone Number: 321-843-3762
- Email: leila.ip@orlandohealth.com
-
Principal Investigator:
- Naren Ramakrishna, MD, Ph. D
-
-
Georgia
-
Atlanta, Georgia, United States, 30308
- Recruiting
- Emory Proton Therapy Center
-
Contact:
- Leann Schilling, MPH, CCRP
- Phone Number: 404-686-0286
- Email: leann.schilling@emory.edu
-
Principal Investigator:
- Mark McDonald, MD
-
-
Illinois
-
Warrenville, Illinois, United States, 60555
- Recruiting
- Northwestern Medicine Chicago Proton Center
-
Contact:
- Don Smith, MS, CCRC
- Phone Number: 630-933-7820
- Email: donald.smith3@nm.org
-
Principal Investigator:
- Stephen Mihalcik, MD
-
-
Kansas
-
Kansas City, Kansas, United States, 66160
- Recruiting
- University of Kansas Proton Therapy Center
-
Contact:
- Amanda Schroeder
- Phone Number: 913-588-1617
- Email: aschroeder3@kumc.edu
-
Principal Investigator:
- Ronny Rotondo, MD
-
Overland Park, Kansas, United States, 66207
- Recruiting
- Kansas City Proton Institute
-
Contact:
- Judy Searcy
- Phone Number: 913-647-4173
- Email: jsearcy@kcuc.com
-
Principal Investigator:
- James Coster, MD
-
-
Louisiana
-
Shreveport, Louisiana, United States, 71103
- Recruiting
- Willis-Knighton Cancer and Proton Therapy Center
-
Contact:
- Briana Barrow, CCRC
- Phone Number: 318-212-8671
- Email: bbarrow@wkhs.com
-
Principal Investigator:
- Lane Rosen, MD
-
-
Maryland
-
Baltimore, Maryland, United States, 21201
- Recruiting
- Maryland Proton Treatment Center
-
Principal Investigator:
- Mark Mishra, MD
-
Contact:
- Caitlin Eggleston
- Phone Number: 410-328-7586
- Email: caitlineggleston@umm.edu
-
-
Michigan
-
Flint, Michigan, United States, 48532
- Recruiting
- McLaren Proton Therapy Center
-
Contact:
- Drita Nuculovic
- Phone Number: 810-342-5674
- Email: drita.nuculovic@mclaren.org
-
Principal Investigator:
- Christian Hyde, MD
-
-
Missouri
-
Saint Louis, Missouri, United States, 63110
- Recruiting
- Washington University in St. Louis
-
Contact:
- Lindsey Mayer, CCRP
- Phone Number: 314-286-2006
- Email: lindseymayer@wustl.edu
-
Principal Investigator:
- Stephanie Perkins, MD
-
-
New Jersey
-
Somerset, New Jersey, United States, 08873
- Recruiting
- ProCure Proton Therapy Center
-
Contact:
- Heba Darwish
- Phone Number: 732-357-2676
- Email: heba.darwish@nj.procure.com
-
Principal Investigator:
- Henry Tsai, MD
-
-
New York
-
New York, New York, United States, 10035
- Recruiting
- New York Proton Center
-
Principal Investigator:
- Charles Simone, MD, FACRO
-
Contact:
- Ryan Holder
- Phone Number: 387 646-968-9055
- Email: rholder@nyproton.com
-
-
Ohio
-
Cincinnati, Ohio, United States, 45044
- Recruiting
- University of Cincinnati Medical Center
-
Contact:
- Christine Vollmer, MBA
- Phone Number: 513-213-3203
- Email: mccordce@ucmail.uc.edu
-
Principal Investigator:
- Luke Pater, MD
-
-
Oklahoma
-
Oklahoma City, Oklahoma, United States, 73142
- Recruiting
- Oklahoma Proton Center
-
Contact:
- Jenny Washington, BSRT(T), CMD
- Phone Number: 405-773-6700
- Email: jenny.washington@okcproton.com
-
Principal Investigator:
- John Chang, MD
-
-
Tennessee
-
Franklin, Tennessee, United States, 37067
- Recruiting
- Tennessee Oncology Proton Center
-
Contact:
- Erick Vides
- Phone Number: 615-716-4736
- Email: evides@tnonc.com
-
Principal Investigator:
- James Gray, MD
-
Knoxville, Tennessee, United States, 37909
- Recruiting
- Thompson Proton Center
-
Principal Investigator:
- Ryan Grover, MD
-
Contact:
- Kristi Simcox
- Phone Number: 865-331-4985
- Email: esimcox@covhlth.com
-
-
Virginia
-
Fairfax, Virginia, United States, 22031
- Recruiting
- Inova Schar Cancer Institute
-
Principal Investigator:
- Gopal Bajaj, MD
-
Contact:
- Sangeetha Moturi
- Phone Number: 571-472-0343
- Email: sangeetha.moturi@inova.org
-
Hampton, Virginia, United States, 23666
- Recruiting
- Hampton University Proton Therapy Institute
-
Contact:
- Donna Sternberg, RN, BSN, OCN
- Phone Number: 757-251-6839
- Email: donna.sternberg@hamptonproton.org
-
Principal Investigator:
- Christopher Sinesi, MD
-
-
Washington
-
Seattle, Washington, United States, 98195-6043
- Recruiting
- University of Washington
-
Contact:
- Erica Peters, CCRC, CPM
- Phone Number: 206-598-7188
- Email: etucker@uw.edu
-
Principal Investigator:
- Jing Zeng, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Radiation Oncology patients
Description
Inclusion Criteria:
- Planned treatment with radiation therapy
- Ability to understand and sign IRB approved consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Treatment with Radiation Therapy
Includes 16 different arms to capture patient data by disease site
|
Outcomes Tracking
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Define outcomes for patients treated at participating institutions
Time Frame: PRN
|
PRN
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Determine strategies necessary to improve patients outcome and decrease toxicities related to treatments and procedures
Time Frame: Annually PRN
|
Annually PRN
|
Improve patient care by an adequate understanding of the results and patient population at participating institutions
Time Frame: Reviewed Annually PRN
|
Reviewed Annually PRN
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Carlos Vargas, MD, Proton Collaborative Group
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2009
Primary Completion (Estimated)
June 1, 2039
Study Registration Dates
First Submitted
December 6, 2010
First Submitted That Met QC Criteria
December 6, 2010
First Posted (Estimated)
December 7, 2010
Study Record Updates
Last Update Posted (Actual)
February 28, 2024
Last Update Submitted That Met QC Criteria
February 26, 2024
Last Verified
February 1, 2024
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- REG001-09
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Neoplasms
-
GlaxoSmithKlineCompleted
-
John M. BuattiNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedUterine Cervical Neoplasms | Prostatic Neoplasms | Rectal Neoplasms | Endometrial Neoplasms | Anus NeoplasmsUnited States
-
Amphia HospitalRecruitingColonic Neoplasms MalignantNetherlands
-
Marquette General Health SystemUpper Michigan Brain Tumor CenterWithdrawnGlioma | MeningiomaUnited States
-
GlaxoSmithKlineRecruitingColonic Neoplasms | Neoplasms, ColonUnited States, Finland, France, Italy, Japan, Netherlands, Norway, Spain, Taiwan, United Kingdom, Australia, Belgium, Brazil, Germany, Greece, Sweden, Turkey, Canada, Korea, Republic of, Argentina, Hungary, Estonia, Portugal, Mexico, Pa...
-
Ann & Robert H Lurie Children's Hospital of ChicagoCompletedBrain Stem Neoplasms, Primary | Neoplasms, Brain StemUnited States
-
GlaxoSmithKlineRecruitingNeoplasms, RectalUnited States, France, Italy, Japan, Spain, United Kingdom, Germany, Korea, Republic of, Canada, Netherlands
-
Russian Society of Colorectal SurgeonsRecruitingNeoplasms,ColorectalRussian Federation
-
Third Affiliated Hospital, Sun Yat-Sen UniversityRecruiting
-
Novartis PharmaceuticalsBayerCompletedColorectal Neoplasms | Rectal Neoplasms | Colonic NeoplasmsUnited States, Germany, Belgium, Canada, Spain, United Kingdom, Taiwan, France, Switzerland, Sweden, Portugal, New Zealand, Italy, Slovakia, Australia, Austria, Brazil, Hong Kong
Clinical Trials on Proton Therapy, Photon Therapy, SRS, Brachytherapy
-
Technische Universität DresdenGerman Cancer Research Center; National Center for Radiation Research in Oncology...RecruitingNon-Small Cell Lung CancerGermany
-
Maastricht Radiation OncologyUniversity of Pennsylvania; Philipps University Marburg Medical Center; University...CompletedCarcinoma, Squamous Cell of Head and NeckNetherlands
-
Centre Francois BaclesseNational Cancer Institute, FranceNot yet recruitingCognitive Impairment | Cavernous Sinus Meningioma | Proton-therapy | Photon RadiotherapyFrance
-
Danish Breast Cancer Cooperative GroupRecruitingEarly Breast Cancer | Radiation Associated Cardiac FailureDenmark
-
University of AarhusOdense University Hospital; Aarhus University Hospital; Rigshospitalet, Denmark; Aalborg University Hospital and other collaboratorsRecruitingProstate Cancer | Radiotherapy Side EffectDenmark
-
Mayo ClinicCompletedBreast CancerUnited States
-
University of FloridaPatient-Centered Outcomes Research InstituteActive, not recruitingProstate CancerUnited States
-
Abramson Cancer Center of the University of PennsylvaniaNational Cancer Institute (NCI)CompletedBreast Cancer | Long-term Effects Secondary to Cancer Therapy in Adults | Skin Reactions Secondary to Radiation TherapyUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); National Institute of Dental and Craniofacial...Active, not recruitingStage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7 | Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7 | Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7United States
-
Massachusetts General HospitalNational Cancer Institute (NCI); American Society of Clinical OncologyRecruitingMyocardial Fibrosis | Breast Cancer | Breast Cancer Stage II | Breast Cancer Female | Breast Cancer Stage IIIUnited States